JP Patent

JP6817287B2 — キラルジアリール大環状分子及びその使用

Assigned to Turning Point Therapeutics Inc · Expires 2021-01-20 · 5y expired

What this patent protects

Patent listed against Augtyro.

Drugs covered by this patent

Patent Metadata

Patent number
JP6817287B2
Jurisdiction
JP
Classification
—
Expires
2021-01-20
Drug substance claim
No
Drug product claim
No
Assignee
Turning Point Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.